Macrophage activation of cGAS and TRIM5 distinguish pandemic and non-pandemic HIV
Zuliani-Alvarez, L.; Larsen, M.; Rasaiyaah, J.; Monit, C.; Perry, S. O.; Sumner, R.; McAlpine-Scott, S.; Dickson, C.; Rifat Faysal, K. M.; Hilditch, L.; Miles, R.; Bibollet-Ruche, F.; Hahn, B. H.; Bocking, T.; Pinotsis, N.; James, L. C.; Jacques, D.; Towers, G. J.
Show abstract
Pandemic viruses remain a global threat to health and economics but how they adapt to become pandemic remains poorly understood. Here we compare pandemic HIV-1(M) and non-pandemic HIV-(O) and HIV-2 strains finding that non-pandemic HIV replicate poorly in myeloid cell models due to activation of cGAS and TRIM5, and ensuing antiviral responses. We use phylogenetics and viral capsid structural biology to define specific differences between pandemic and non-pandemic HIV capsids and demonstrate that their genetic reversal in HIV-1(M) mutants causes TRIM5, cGAS and innate immune activation. We propose a model in which the parental lineage of pandemic HIV-1(M) has uniquely evolved a dynamic capsid that avoids activation of cGAS and TRIM5 to establish cloaked replication in myeloid cells. The unique adaptations of the pandemic virus lineage suggests a role in effective human-to-human transmissibility and highlight the importance of avoiding innate immune activation during pandemic human-to-human viral transmission.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.